ERBB2 and breast cancer: In addition, random DNA showed no binding preference to all the cell lines (Figure 4B). The results indicated that the aptamer HB5 could preferentially bind to HER2-positive breast cancer cells, possibly by recognizing the HER2 structure on the surface of these cells.